Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization

by Sriharsha Gummadi, MD, Maria Stanczak, MS, RDMS, RVT, Andrej Lyshchik, MD, PhD, Flemming Forsberg, PhD, Colette M. Shaw, MD, John R. Eisenbrey, PhD
Published 2018-06-01

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy

by Gregory S. Alexander, Joshua D. Palmer, Madalina Tuluc, Jianqing Lin, Adam P. Dicker, Voichita Bar-Ad, Larry A Harshyne, Jennifer Louie, Colette M. Shaw, D. Craig Hooper, Bo Lu
Published 2016-09-01